DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,950,298 | +3.8% | 40,106 | +0.4% | 3.38% | +11.2% |
| Q2 2023 | $9,582,960 | -4.8% | 39,929 | +0.0% | 3.03% | -9.6% |
| Q1 2023 | $10,061,185 | -2.1% | 39,919 | +3.1% | 3.36% | -9.5% |
| Q4 2022 | $10,274,939 | -0.1% | 38,712 | -2.8% | 3.71% | -5.1% |
| Q3 2022 | $10,287,000 | +0.6% | 39,826 | -1.2% | 3.91% | +7.7% |
| Q2 2022 | $10,221,000 | -14.2% | 40,312 | -0.7% | 3.63% | +1.3% |
| Q1 2022 | $11,908,000 | -12.2% | 40,593 | -1.6% | 3.58% | -6.5% |
| Q4 2021 | $13,568,000 | +6.0% | 41,244 | -1.9% | 3.83% | -5.6% |
| Q3 2021 | $12,805,000 | +5.7% | 42,062 | -6.8% | 4.06% | +7.8% |
| Q2 2021 | $12,114,000 | +13.0% | 45,141 | -5.2% | 3.76% | +10.3% |
| Q1 2021 | $10,719,000 | -2.3% | 47,623 | -3.6% | 3.41% | -4.7% |
| Q4 2020 | $10,971,000 | -0.6% | 49,385 | -3.6% | 3.58% | -8.8% |
| Q3 2020 | $11,034,000 | +12.6% | 51,241 | -7.5% | 3.93% | +7.1% |
| Q2 2020 | $9,797,000 | +25.3% | 55,407 | -1.9% | 3.66% | +6.5% |
| Q1 2020 | $7,817,000 | -11.8% | 56,475 | -2.2% | 3.44% | +8.5% |
| Q4 2019 | $8,860,000 | +5.1% | 57,730 | -1.1% | 3.17% | -0.2% |
| Q3 2019 | $8,432,000 | +0.2% | 58,371 | -0.8% | 3.18% | +1.6% |
| Q2 2019 | $8,414,000 | +8.7% | 58,865 | +0.4% | 3.12% | +3.5% |
| Q1 2019 | $7,741,000 | +26.8% | 58,638 | -1.0% | 3.02% | +11.2% |
| Q4 2018 | $6,107,000 | -6.3% | 59,222 | -1.3% | 2.71% | +10.3% |
| Q3 2018 | $6,521,000 | +13.4% | 59,992 | +3.0% | 2.46% | +1.1% |
| Q2 2018 | $5,748,000 | +3.9% | 58,255 | +3.1% | 2.43% | +3.3% |
| Q1 2018 | $5,533,000 | +7.5% | 56,506 | +1.9% | 2.36% | +11.1% |
| Q4 2017 | $5,147,000 | +43.4% | 55,456 | +32.6% | 2.12% | +13.5% |
| Q3 2017 | $3,589,000 | +7.9% | 41,829 | +6.1% | 1.87% | +4.1% |
| Q2 2017 | $3,326,000 | +3.6% | 39,421 | +5.0% | 1.80% | +0.7% |
| Q1 2017 | $3,209,000 | +15.4% | 37,526 | +5.1% | 1.78% | +10.8% |
| Q4 2016 | $2,780,000 | +95.5% | 35,720 | +96.8% | 1.61% | +96.1% |
| Q3 2016 | $1,422,000 | +117.8% | 18,150 | +180.5% | 0.82% | +90.3% |
| Q2 2016 | $653,000 | +114.8% | 6,471 | +101.8% | 0.43% | +113.4% |
| Q1 2016 | $304,000 | +721.6% | 3,206 | +628.6% | 0.20% | +676.9% |
| Q3 2015 | $37,000 | -2.6% | 440 | 0.0% | 0.03% | +8.3% |
| Q2 2015 | $38,000 | +2.7% | 440 | 0.0% | 0.02% | 0.0% |
| Q1 2015 | $37,000 | – | 440 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |